Logo image of NR

NEWPARK RESOURCES INC (NR) Stock Fundamental Analysis

NYSE:NR - New York Stock Exchange, Inc. - US6517185046 - Common Stock - Currency: USD

7.25  -0.37 (-4.86%)

After market: 7.25 0 (0%)

Fundamental Rating

4

NR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 62 industry peers in the Energy Equipment & Services industry. No worries on liquidiy or solvency for NR as it has an excellent financial health rating, but there are worries on the profitability. NR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NR was profitable.
In the past year NR had a positive cash flow from operations.
NR had negative earnings in 4 of the past 5 years.
In multiple years NR reported negative operating cash flow during the last 5 years.
NR Yearly Net Income VS EBIT VS OCF VS FCFNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.05%, NR is doing worse than 96.61% of the companies in the same industry.
NR's Return On Equity of -48.08% is on the low side compared to the rest of the industry. NR is outperformed by 89.83% of its industry peers.
NR has a Return On Invested Capital of 9.30%. This is in the better half of the industry: NR outperforms 69.49% of its industry peers.
Industry RankSector Rank
ROA -39.05%
ROE -48.08%
ROIC 9.3%
ROA(3y)-1.35%
ROA(5y)-3.37%
ROE(3y)-2.31%
ROE(5y)-5.17%
ROIC(3y)N/A
ROIC(5y)N/A
NR Yearly ROA, ROE, ROICNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

NR's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 8.02%, NR is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
NR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.13%, NR is in line with its industry, outperforming 45.76% of the companies in the same industry.
NR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.02%
PM (TTM) N/A
GM 24.13%
OM growth 3YN/A
OM growth 5Y-4.51%
PM growth 3YN/A
PM growth 5Y-10.71%
GM growth 3Y67.42%
GM growth 5Y-0.53%
NR Yearly Profit, Operating, Gross MarginsNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NR is creating some value.
NR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NR has less shares outstanding
Compared to 1 year ago, NR has an improved debt to assets ratio.
NR Yearly Shares OutstandingNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
NR Yearly Total Debt VS Total AssetsNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 6.43 indicates that NR is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.43, NR belongs to the best of the industry, outperforming 96.61% of the companies in the same industry.
The Debt to FCF ratio of NR is 0.35, which is an excellent value as it means it would take NR, only 0.35 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NR (0.35) is better than 91.53% of its industry peers.
NR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
NR has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. NR outperforms 86.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.35
Altman-Z 6.43
ROIC/WACC1.05
WACC8.86%
NR Yearly LT Debt VS Equity VS FCFNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

NR has a Current Ratio of 2.29. This indicates that NR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.29, NR is in the better half of the industry, outperforming 64.41% of the companies in the same industry.
NR has a Quick Ratio of 2.00. This is a normal value and indicates that NR is financially healthy and should not expect problems in meeting its short term obligations.
NR has a Quick ratio of 2.00. This is in the better half of the industry: NR outperforms 74.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2
NR Yearly Current Assets VS Current LiabilitesNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

NR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.21%.
NR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.04% yearly.
Looking at the last year, NR shows a very negative growth in Revenue. The Revenue has decreased by -38.43% in the last year.
NR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.56% yearly.
EPS 1Y (TTM)-21.21%
EPS 3YN/A
EPS 5Y-3.04%
EPS Q2Q%-100%
Revenue 1Y (TTM)-38.43%
Revenue growth 3Y15.02%
Revenue growth 5Y-4.56%
Sales Q2Q%-77.73%

3.2 Future

The Earnings Per Share is expected to grow by 16.17% on average over the next years. This is quite good.
The Revenue is expected to decrease by -28.57% on average over the next years. This is quite bad
EPS Next Y33.9%
EPS Next 2Y11.69%
EPS Next 3Y16.17%
EPS Next 5YN/A
Revenue Next Year-63.28%
Revenue Next 2Y-43.4%
Revenue Next 3Y-28.57%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NR Yearly Revenue VS EstimatesNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
NR Yearly EPS VS EstimatesNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.88 indicates a quite expensive valuation of NR.
Based on the Price/Earnings ratio, NR is valued a bit more expensive than the industry average as 64.41% of the companies are valued more cheaply.
NR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.95.
With a Price/Forward Earnings ratio of 19.37, NR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, NR is valued a bit more expensive than 66.10% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.99, NR is valued at the same level.
Industry RankSector Rank
PE 27.88
Fwd PE 19.37
NR Price Earnings VS Forward Price EarningsNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

NR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NR is more expensive than 67.80% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as NR.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 8.6
NR Per share dataNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

NR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NR's earnings are expected to grow with 16.17% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y11.69%
EPS Next 3Y16.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEWPARK RESOURCES INC

NYSE:NR (12/18/2024, 8:04:00 PM)

After market: 7.25 0 (0%)

7.25

-0.37 (-4.86%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners85.89%
Inst Owner Change-0.79%
Ins Owners8.75%
Ins Owner Change0.01%
Market Cap627.13M
Analysts83.33
Price Target11.22 (54.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.84%
Min EPS beat(2)-100%
Max EPS beat(2)50.33%
EPS beat(4)2
Avg EPS beat(4)-5.34%
Min EPS beat(4)-100%
Max EPS beat(4)76.52%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-20.8%
Max Revenue beat(2)2.64%
Revenue beat(4)1
Avg Revenue beat(4)-6.71%
Min Revenue beat(4)-20.8%
Max Revenue beat(4)2.64%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.22%
PT rev (3m)-2.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.2%
EPS NY rev (1m)0%
EPS NY rev (3m)5.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-67.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-47.19%
Valuation
Industry RankSector Rank
PE 27.88
Fwd PE 19.37
P/S 1.26
P/FCF 15.91
P/OCF 7.99
P/B 1.98
P/tB 2.43
EV/EBITDA 8.6
EPS(TTM)0.26
EY3.59%
EPS(NY)0.37
Fwd EY5.16%
FCF(TTM)0.46
FCFY6.29%
OCF(TTM)0.91
OCFY12.52%
SpS5.74
BVpS3.66
TBVpS2.98
PEG (NY)0.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.05%
ROE -48.08%
ROCE 11.77%
ROIC 9.3%
ROICexc 10.65%
ROICexgc 13.27%
OM 8.02%
PM (TTM) N/A
GM 24.13%
FCFM 7.93%
ROA(3y)-1.35%
ROA(5y)-3.37%
ROE(3y)-2.31%
ROE(5y)-5.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.24%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.7%
OM growth 3YN/A
OM growth 5Y-4.51%
PM growth 3YN/A
PM growth 5Y-10.71%
GM growth 3Y67.42%
GM growth 5Y-0.53%
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.35
Debt/EBITDA 0.08
Cap/Depr 131.66%
Cap/Sales 7.86%
Interest Coverage 6.58
Cash Conversion 112.9%
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2
Altman-Z 6.43
F-Score6
WACC8.86%
ROIC/WACC1.05
Cap/Depr(3y)72.72%
Cap/Depr(5y)69.63%
Cap/Sales(3y)3.64%
Cap/Sales(5y)3.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.21%
EPS 3YN/A
EPS 5Y-3.04%
EPS Q2Q%-100%
EPS Next Y33.9%
EPS Next 2Y11.69%
EPS Next 3Y16.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.43%
Revenue growth 3Y15.02%
Revenue growth 5Y-4.56%
Sales Q2Q%-77.73%
Revenue Next Year-63.28%
Revenue Next 2Y-43.4%
Revenue Next 3Y-28.57%
Revenue Next 5YN/A
EBIT growth 1Y-19.82%
EBIT growth 3YN/A
EBIT growth 5Y-8.86%
EBIT Next Year41.61%
EBIT Next 3Y26.34%
EBIT Next 5YN/A
FCF growth 1Y160.47%
FCF growth 3Y20.95%
FCF growth 5Y31.06%
OCF growth 1Y275.22%
OCF growth 3Y21.47%
OCF growth 5Y9.54%